Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Tarloxotinib Cation
2. Tarloxotinib Ion
3. 1636938-13-0
4. H8768ul06v
5. [(e)-4-[[4-(3-bromo-4-chloroanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]-4-oxobut-2-enyl]-dimethyl-[(3-methyl-5-nitroimidazol-4-yl)methyl]azanium
6. Th-4000
7. Tarloxotinib [who-dd]
8. Unii-h8768ul06v
9. Gtpl9409
10. Chembl4297661
11. Schembl19733352
12. Pr610
13. Db14944
14. Q27279755
| Molecular Weight | 601.9 g/mol |
|---|---|
| Molecular Formula | C24H24BrClN9O3+ |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | 600.08740 g/mol |
| Monoisotopic Mass | 600.08740 g/mol |
| Topological Polar Surface Area | 143 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 1 |
| Complexity | 863 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
72
PharmaCompass offers a list of Tarloxotinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tarloxotinib manufacturer or Tarloxotinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tarloxotinib manufacturer or Tarloxotinib supplier.
PharmaCompass also assists you with knowing the Tarloxotinib API Price utilized in the formulation of products. Tarloxotinib API Price is not always fixed or binding as the Tarloxotinib Price is obtained through a variety of data sources. The Tarloxotinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tarloxotinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tarloxotinib, including repackagers and relabelers. The FDA regulates Tarloxotinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tarloxotinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tarloxotinib supplier is an individual or a company that provides Tarloxotinib active pharmaceutical ingredient (API) or Tarloxotinib finished formulations upon request. The Tarloxotinib suppliers may include Tarloxotinib API manufacturers, exporters, distributors and traders.
Tarloxotinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tarloxotinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tarloxotinib GMP manufacturer or Tarloxotinib GMP API supplier for your needs.
A Tarloxotinib CoA (Certificate of Analysis) is a formal document that attests to Tarloxotinib's compliance with Tarloxotinib specifications and serves as a tool for batch-level quality control.
Tarloxotinib CoA mostly includes findings from lab analyses of a specific batch. For each Tarloxotinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tarloxotinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Tarloxotinib EP), Tarloxotinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tarloxotinib USP).
